Clinical Study
Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer
Table 2
Correlation matrix of imaging biomarkers and clinical parameters.
| | | SUVmax | SUVmean | UVP | MTV | Ktransmax | Ktranskur | Kepmax | Kepkur | iAUCmax | iAUCkur | ADCmin | ADCmean | ADCkur | PSA | GS |
| SUVmax | Correlation | 1 | 0.90 | 0.69 | 0.59 | 0.35 | 0.15 | 0.18 | −0.04 | 0.40 | 0.25 | −0.04 | −0.19 | 0.10 | 0.46 | −0.31 | value | | <0.01 | <0.01 | <0.01 | 0.06 | 0.41 | 0.35 | 0.85 | 0.03 | 0.18 | 0.82 | 0.31 | 0.60 | 0.01 | 0.10 | SUVmean | Correlation | | 1 | 0.56 | 0.42 | 0.19 | 0.06 | −0.02 | −0.19 | 0.28 | 0.25 | 0.09 | −0.30 | 0.14 | 0.39 | −0.33 | value | | | <0.01 | 0.02 | 0.30 | 0.76 | 0.92 | 0.31 | 0.13 | 0.17 | 0.64 | 0.10 | 0.47 | 0.03 | 0.07 | UVP | Correlation | | | 1 | 0.98 | 0.37 | 0.31 | 0.34 | 0.30 | 0.51 | 0.45 | −0.41 | −0.31 | 0.37 | 0.76 | 0.16 | value | | | | <0.01 | 0.04 | 0.09 | 0.06 | 0.11 | <0.01 | 0.01 | 0.02 | 0.09 | 0.04 | <0.01 | 0.40 | MTV | Correlation | | | | 1 | 0.39 | 0.25 | 0.41 | 0.40 | 0.51 | 0.48 | −0.47 | −0.28 | 0.40 | 0.75 | 0.25 | value | | | | | 0.03 | 0.17 | 0.02 | 0.03 | <0.01 | 0.01 | 0.01 | 0.12 | 0.03 | <0.01 | 0.18 | Ktransmax | Correlation | | | | | 1 | 1 | 0.80 | 0.55 | 0.60 | 0.47 | −0.24 | 0.02 | 0.37 | 0.18 | 0.04 | value | | | | | | <0.01 | <0.01 | <0.01 | <0.01 | 0.01 | 0.20 | 0.93 | 0.04 | 0.34 | 0.83 | Ktranskur | Correlation | | | | | | 1 | 0.74 | 0.71 | 0.34 | 0.78 | 0.01 | −0.09 | 0.30 | 0.10 | 0.25 | value | | | | | | | <0.01 | <0.01 | 0.07 | <0.01 | 0.95 | 0.64 | 0.10 | 0.58 | 0.17 | Kepmax | Correlation | | | | | | | 1 | 0.80 | 0.50 | 0.47 | −0.31 | −0.04 | 0.21 | 0.15 | 0.21 | value | | | | | | | | 0.00 | 0.00 | 0.01 | 0.09 | 0.84 | 0.26 | 0.41 | 0.25 | Kepkur | Correlation | | | | | | | | 1 | 0.32 | 0.47 | −0.26 | −0.11 | 0.24 | 0.20 | 0.41 | value | | | | | | | | | 0.09 | 0.01 | 0.15 | 0.57 | 0.19 | 0.29 | 0.02 | iAUCmax | Correlation | | | | | | | | | 1 | 0.36 | −0.25 | −0.01 | 0.26 | 0.30 | 0.11 | value | | | | | | | | | | 0.046 | 0.17 | 0.95 | 0.16 | 0.10 | 0.57 | iAUCkur | Correlation | | | | | | | | | | 1 | −0.08 | −0.35 | 0.30 | 0.33 | 0.36 | value | | | | | | | | | | | 0.68 | 0.05 | 0.10 | 0.07 | 0.049 | ADCmin | Correlation | | | | | | | | | | | 1 | 0.14 | −0.08 | −0.36 | −0.33 | value | | | | | | | | | | | | 0.44 | 0.66 | 0.046 | 0.07 | ADCmean | Correlation | | | | | | | | | | | | 1 | −0.20 | −0.38 | −0.22 | value | | | | | | | | | | | | | 0.28 | 0.04 | 0.23 | ADCkur | Correlation | | | | | | | | | | | | | 1 | 0.23 | 0.35 | value | | | | | | | | | | | | | | 0.22 | 0.06 | PSA | Correlation | | | | | | | | | | | | | | 1 | 0.17 | value | | | | | | | | | | | | | | | 0.35 | GS | Correlation | | | | | | | | | | | | | | | 1 | value | | | | | | | | | | | | | | | |
|
|
Statistically significant by Spearman’s correlation method. PSA, prostate-specific antigen; GS, Gleason score. |